Trial description:
An International, Phase 3, Open-label, Randomized Study of BGB-3111 Compared with Bendamustine plus Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma
Contact name:
Dr George Follows
Trial start date:
Wednesday, May 23, 2018
Trial end date:
Thursday, February 28, 2019
Trial tumour type:
Haematological
Show on Radiotherapy:
No
